{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:48:40Z","timestamp":1761896920204,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.5604\/01.3001.0012.7208","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T06:32:31Z","timestamp":1541399551000},"page":"1072-1077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improvement in Waldenstr\u00f6m\u2019s Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals"],"prefix":"10.1016","volume":"17","author":[{"given":"Mattia","family":"Crespi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giulia","family":"Demarzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Brunacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Pellegatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ballestrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo G.","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0012.7208_bib0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7208_bib0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2468-1253(17)30048-1","article-title":"Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study","volume":"2","author":"Petta","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7208_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2468-1253(17)30045-6","article-title":"Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7208_bib0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2016.05.010","article-title":"Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study","volume":"65","author":"Belli","year":"2016","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7208_bib0025","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.28923","article-title":"Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy","volume":"65","author":"Flemming","year":"2017","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7208_bib0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/apt.13821","article-title":"Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/01.3001.0012.7208_bib0035","doi-asserted-by":"crossref","first-page":"638185","DOI":"10.1155\/2012\/638185","article-title":"Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy","volume":"2012","author":"Arcaini","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.5604\/01.3001.0012.7208_bib0040","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2016-05-714667","article-title":"Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection","volume":"128","author":"Arcaini","year":"2016","journal-title":"Blood"},{"key":"10.5604\/01.3001.0012.7208_bib0040a","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin\u2019s lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.7208_bib0045","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.3748\/wjg.v22.i38.8447","article-title":"Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma","volume":"22","author":"Merli","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7208_bib0050","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2017","journal-title":"JAMA"},{"key":"10.5604\/01.3001.0012.7208_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7208_bib0060","first-page":"165670","article-title":"Waldenstr\u00f6m Macroglobulinemia in hepatitis C: case report and review of the current literature","volume":"2014","author":"Nipp","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"10.5604\/01.3001.0012.7208_bib0065","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.3748\/wjg.v22.i27.6214","article-title":"Hepatitis C virus - associated B cell non-Hodgkin\u2019s lymphoma","volume":"22","author":"Mihaila","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7208_bib0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jvh.12518","article-title":"The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a metaanalysis","volume":"23","author":"Peveling-Oberhag","year":"2016","journal-title":"J Viral Hep"},{"key":"10.5604\/01.3001.0012.7208_bib0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jncimonographs\/lgu001","article-title":"Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia\/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Slager","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.5604\/01.3001.0012.7208_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.20724","article-title":"Hepatitis C viral infection is not associated with Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"82","author":"Leleu","year":"2007","journal-title":"Am J Hematol"},{"key":"10.5604\/01.3001.0012.7208_bib0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5604\/16652681.1231595","article-title":"Aplastic anemia and severe myelosuppression with boceprevir or simeprevir-containing hepatitis C virus treatment","volume":"16","author":"Sen\u00edn","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.5604\/01.3001.0012.7208_bib0090","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1365-2133.2004.06207.x","article-title":"Leucocytoclastic vasculitis, hepatitis C virus-associated mixed cryoglobulinaemia with biclonal gammopathy and Waldenstr\u00f6m macroglobulinaemia","volume":"151","author":"\u00c1lvarez-Ruiz","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.5604\/01.3001.0012.7208_bib0095","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood-2016-04-711234","article-title":"Treatment recommendations from the Eighth International Workshop on Waldenstrom\u2019s Macroglobulinemia","volume":"128","author":"Leblond","year":"2016","journal-title":"Blood"},{"key":"10.5604\/01.3001.0012.7208_bib0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-0035-1550432","article-title":"Platelet dysfunction: status of thrombopoietin in thrombocytopenia associated with chronic liver failure","volume":"41","author":"Giannini","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.5604\/01.3001.0012.7208_bib0105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2036.2009.04201.x","article-title":"Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients","volume":"31","author":"Giannini","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/01.3001.0012.7208_bib0110","doi-asserted-by":"crossref","first-page":"e0185728","DOI":"10.1371\/journal.pone.0185728","article-title":"Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network","volume":"12","author":"Kondili","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:38:51Z","timestamp":1761647931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119310701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1665268119310701"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0012.7208","relation":{},"ISSN":["1665-2681"],"issn-type":[{"type":"print","value":"1665-2681"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in Waldenstr\u00f6m\u2019s Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0012.7208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}